Cisblok 5ml (Cisatracurium Besylate USP Vials) 2mg/mlx5ml

Cisblok 5ml contains Cisatracurium Besylate USP, a neuromuscular blocking agent in 2mg/ml vials. Used for muscle relaxation during surgical procedures and mechanical ventilation. Store between 2-8°C to maintain potency. Ideal for controlled clinical settings requiring precise dosing.

Strength

2mg/mlx5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ABBOTT INDIA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cisatracurium Besylate USP is a non-depolarizing neuromuscular blocker used to relax muscles during surgery or intensive care. It helps facilitate endotracheal intubation and maintain controlled ventilation by preventing spontaneous muscle movement. Often prescribed when rapid onset and intermediate duration of action are required. Commonly used in operating rooms and critical care units.

Side Effects

Cisatracurium Besylate USP works by blocking nerve signals to muscles, leading to temporary paralysis. Effects typically appear within 2-3 minutes and last about 30-60 minutes depending on dosage. Patients remain conscious unless sedation is administered. Recovery occurs as the drug is naturally metabolized in the body.

Precautions & Warnings

Store Cisblok 5ml vials refrigerated between 2-8°C and protect from light. Use only in clinical settings with trained personnel and emergency equipment available. Inform healthcare providers of any allergies or neuromuscular conditions before administration. Avoid freezing or exposure to extreme temperatures.

Avoid Interactions

Cisatracurium Besylate USP may interact with certain antibiotics, magnesium salts, or other muscle relaxants, potentially enhancing its effects. General anesthetics and lithium can also prolong neuromuscular blockade. Always disclose all medications to your healthcare provider to assess potential interactions.

References

Frequently Asked Questions

It is used to relax muscles during surgery or mechanical ventilation in clinical settings.

Store between 2-8°C and protect from light; do not freeze.

Effects typically begin within 2-3 minutes after administration.

No, it is intended for use in controlled clinical environments only.

Possible effects include temporary muscle weakness or skin reactions at the injection site.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.